Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. Reported prevalence rates vary substantially between 1:500 (0.2%) and 1:3,000 (0.03%), which may be attributed to different study designs and population characteristics. Prevalence data for Germany is not available. Consequently, this study aimed (1) to quantify age- and gender-specific clinically diagnosed HCM prevalence in Germany based on the analysis of health care claims data of > 5 million insurants in 2015, and (2) to analyze temporal prevalence trends from 2011 to 2015.Data were extracted from the InGef (Insitute for Applied Health Research) database, which is an anonymized healthcare claims database with longitudinal data from patients insured in one of a...
Introduction: Hypertrophic cardiomyopathy (HCM) is a common disorder with various manifestations, in...
AbstractOBJECTIVESThe purpose of this study was to assess the extent to which hypertrophic cardiomyo...
Importance: It is unclear whether hypertrophic cardiomyopathy (HCM) conveys excess mortality when co...
AbstractHypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which pre...
BACKGROUND Over the last 50 years, the epidemiology of hypertrophic cardiomyopathy (HCM) has changed...
Temporal trends of the prevalence and incidence of hypertrophic cardiomyopathy (HCM) have not been w...
Background: Over the last 50 years, the epidemiology of hypertrophic cardiomyopathy (HCM) has change...
International audienceBackground - Our knowledge of hypertrophic cardiomyopathy (HCM) mainly origina...
Background: Hypertrophic cardiomyopathy (HCM) is a genetic disorder with the prevalence of 1 in 500 ...
Objectives The prevalence of AndersoneFabry disease (AFD) in patients presenting with unexplained le...
Objectives: The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained l...
National registries are advocated as instrumental to the solution of rarity-related problems for pat...
Background: Patients with hypertrophic cardiomyopathy (HCM) are generally regarded as having increas...
Objectives: The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained l...
Hypertrophic cardiomyopathy (HCM) causes considerable morbidity and mortality, including sudden deat...
Introduction: Hypertrophic cardiomyopathy (HCM) is a common disorder with various manifestations, in...
AbstractOBJECTIVESThe purpose of this study was to assess the extent to which hypertrophic cardiomyo...
Importance: It is unclear whether hypertrophic cardiomyopathy (HCM) conveys excess mortality when co...
AbstractHypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which pre...
BACKGROUND Over the last 50 years, the epidemiology of hypertrophic cardiomyopathy (HCM) has changed...
Temporal trends of the prevalence and incidence of hypertrophic cardiomyopathy (HCM) have not been w...
Background: Over the last 50 years, the epidemiology of hypertrophic cardiomyopathy (HCM) has change...
International audienceBackground - Our knowledge of hypertrophic cardiomyopathy (HCM) mainly origina...
Background: Hypertrophic cardiomyopathy (HCM) is a genetic disorder with the prevalence of 1 in 500 ...
Objectives The prevalence of AndersoneFabry disease (AFD) in patients presenting with unexplained le...
Objectives: The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained l...
National registries are advocated as instrumental to the solution of rarity-related problems for pat...
Background: Patients with hypertrophic cardiomyopathy (HCM) are generally regarded as having increas...
Objectives: The prevalence of Anderson-Fabry disease (AFD) in patients presenting with unexplained l...
Hypertrophic cardiomyopathy (HCM) causes considerable morbidity and mortality, including sudden deat...
Introduction: Hypertrophic cardiomyopathy (HCM) is a common disorder with various manifestations, in...
AbstractOBJECTIVESThe purpose of this study was to assess the extent to which hypertrophic cardiomyo...
Importance: It is unclear whether hypertrophic cardiomyopathy (HCM) conveys excess mortality when co...